← Open Payments lookup

OMOLARA FYLE THORPE: Open Payments

NPI 1578532065 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$614 in 5 payments from 5 companies in 2025. Trend: 2023 $433 · 2024 $626 · 2025 $614

Food & beverage: $614
CompanyPaymentsAmount
SCPHARMACEUTICALS INC.1$150
Astellas Pharma US Inc1$129
Gilead Sciences, Inc.1$122
Kowa Pharmaceuticals America, Inc.1$120
Neurocrine BioSciences, Inc.1$94

Products named: FUROSCIX, Veozah, Descovy, ZORYVE, INGREZZA.

Industry payments across MO — which companies pay providers there.